Losartan is an angiotensin II receptor blocker used to treat mild to moderate hypertension as well as stroke in some cases. Losartan is also been used in slowing down long term kidney damage due to type II diabetes. Losartan by blocking angiotensin II receptor help arteries and blood vessels to relax and widen which makes blood flow easy through them. Losartan is available with oral route of administration. The side effects of losartan includes, upper respiratory tract infections, dizziness, stuffy nose, back pain and fatigue.
MARKET DYNAMICS
The key market drivers for Losartan Market Includes, rising prevalence of cardiovascular disorders such as, hypertension, stroke, heart failure. Moreover, increasing geriatric population across the globe is also fueling the market growth. Whereas, wide range of side effects from losartan is expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Losartan Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Losartan market with detailed market segmentation by indication and route of administration. The Losartan Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Losartan Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Losartan Market is segmented on the basis of indication and route of administration. On the basis of indication the market is segmented as, blood pressure, stroke and heart disease. And on the basis of route of administration the market is segmented as by oral route.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Losartan Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Losartan Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Losartan Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Losartan Market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Losartan Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Losartan Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Losartan Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Losartan Market in these regions.
MARKET PLAYERS
The report covers key developments in the Losartan Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Losartan Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Losartan market in the global market. Below mentioned is the list of few companies engaged in the Losartan Market.
The report also includes the profiles of key players in Losartan Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Torrent Pharmaceuticals
- Macleods Pharmaceuticals
- Merck
- Teva Pharmaceuticals
- Lupin
- Cipla
- Sandoz
- Sun Pharmaceuticals
- Unichem Laboratories
- Dr. Reddy's Laboratories
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Losartan Market - By Indication
1.3.2 Losartan Market - By Route of Administration
1.3.3 Losartan Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LOSARTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LOSARTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LOSARTAN MARKET - GLOBAL MARKET ANALYSIS
6.1. LOSARTAN - GLOBAL MARKET OVERVIEW
6.2. LOSARTAN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. LOSARTAN MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. BLOOD PRESSURE
7.3.1. Overview
7.3.2. Blood Pressure Market Forecast and Analysis
7.4. STROKE
7.4.1. Overview
7.4.2. Stroke Market Forecast and Analysis
7.5. HEART DISEASE
7.5.1. Overview
7.5.2. Heart Disease Market Forecast and Analysis
8. LOSARTAN MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
9. LOSARTAN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Losartan Market Overview
9.1.2 North America Losartan Market Forecasts and Analysis
9.1.3 North America Losartan Market Forecasts and Analysis - By Indication
9.1.4 North America Losartan Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Losartan Market Forecasts and Analysis - By Countries
9.1.5.1 United States Losartan Market
9.1.5.1.1 United States Losartan Market by Indication
9.1.5.1.2 United States Losartan Market by Route of Administration
9.1.5.2 Canada Losartan Market
9.1.5.2.1 Canada Losartan Market by Indication
9.1.5.2.2 Canada Losartan Market by Route of Administration
9.1.5.3 Mexico Losartan Market
9.1.5.3.1 Mexico Losartan Market by Indication
9.1.5.3.2 Mexico Losartan Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Losartan Market Overview
9.2.2 Europe Losartan Market Forecasts and Analysis
9.2.3 Europe Losartan Market Forecasts and Analysis - By Indication
9.2.4 Europe Losartan Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Losartan Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Losartan Market
9.2.5.1.1 Germany Losartan Market by Indication
9.2.5.1.2 Germany Losartan Market by Route of Administration
9.2.5.2 France Losartan Market
9.2.5.2.1 France Losartan Market by Indication
9.2.5.2.2 France Losartan Market by Route of Administration
9.2.5.3 Italy Losartan Market
9.2.5.3.1 Italy Losartan Market by Indication
9.2.5.3.2 Italy Losartan Market by Route of Administration
9.2.5.4 Spain Losartan Market
9.2.5.4.1 Spain Losartan Market by Indication
9.2.5.4.2 Spain Losartan Market by Route of Administration
9.2.5.5 United Kingdom Losartan Market
9.2.5.5.1 United Kingdom Losartan Market by Indication
9.2.5.5.2 United Kingdom Losartan Market by Route of Administration
9.2.5.6 Rest of Europe Losartan Market
9.2.5.6.1 Rest of Europe Losartan Market by Indication
9.2.5.6.2 Rest of Europe Losartan Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Losartan Market Overview
9.3.2 Asia-Pacific Losartan Market Forecasts and Analysis
9.3.3 Asia-Pacific Losartan Market Forecasts and Analysis - By Indication
9.3.4 Asia-Pacific Losartan Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Losartan Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Losartan Market
9.3.5.1.1 Australia Losartan Market by Indication
9.3.5.1.2 Australia Losartan Market by Route of Administration
9.3.5.2 China Losartan Market
9.3.5.2.1 China Losartan Market by Indication
9.3.5.2.2 China Losartan Market by Route of Administration
9.3.5.3 India Losartan Market
9.3.5.3.1 India Losartan Market by Indication
9.3.5.3.2 India Losartan Market by Route of Administration
9.3.5.4 Japan Losartan Market
9.3.5.4.1 Japan Losartan Market by Indication
9.3.5.4.2 Japan Losartan Market by Route of Administration
9.3.5.5 South Korea Losartan Market
9.3.5.5.1 South Korea Losartan Market by Indication
9.3.5.5.2 South Korea Losartan Market by Route of Administration
9.3.5.6 Rest of Asia-Pacific Losartan Market
9.3.5.6.1 Rest of Asia-Pacific Losartan Market by Indication
9.3.5.6.2 Rest of Asia-Pacific Losartan Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Losartan Market Overview
9.4.2 Middle East and Africa Losartan Market Forecasts and Analysis
9.4.3 Middle East and Africa Losartan Market Forecasts and Analysis - By Indication
9.4.4 Middle East and Africa Losartan Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Losartan Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Losartan Market
9.4.5.1.1 South Africa Losartan Market by Indication
9.4.5.1.2 South Africa Losartan Market by Route of Administration
9.4.5.2 Saudi Arabia Losartan Market
9.4.5.2.1 Saudi Arabia Losartan Market by Indication
9.4.5.2.2 Saudi Arabia Losartan Market by Route of Administration
9.4.5.3 U.A.E Losartan Market
9.4.5.3.1 U.A.E Losartan Market by Indication
9.4.5.3.2 U.A.E Losartan Market by Route of Administration
9.4.5.4 Rest of Middle East and Africa Losartan Market
9.4.5.4.1 Rest of Middle East and Africa Losartan Market by Indication
9.4.5.4.2 Rest of Middle East and Africa Losartan Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Losartan Market Overview
9.5.2 South and Central America Losartan Market Forecasts and Analysis
9.5.3 South and Central America Losartan Market Forecasts and Analysis - By Indication
9.5.4 South and Central America Losartan Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Losartan Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Losartan Market
9.5.5.1.1 Brazil Losartan Market by Indication
9.5.5.1.2 Brazil Losartan Market by Route of Administration
9.5.5.2 Argentina Losartan Market
9.5.5.2.1 Argentina Losartan Market by Indication
9.5.5.2.2 Argentina Losartan Market by Route of Administration
9.5.5.3 Rest of South and Central America Losartan Market
9.5.5.3.1 Rest of South and Central America Losartan Market by Indication
9.5.5.3.2 Rest of South and Central America Losartan Market by Route of Administration
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LOSARTAN MARKET, KEY COMPANY PROFILES
11.1. TORRENT PHARMACEUTICALS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MACLEODS PHARMACEUTICALS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. TEVA PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CIPLA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANDOZ
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. UNICHEM LABORATORIES
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. DR. REDDY'S LABORATORIES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Torrent Pharmaceuticals
2. Macleods Pharmaceuticals
3. Merck
4. Teva Pharmaceuticals
5. Lupin
6. Cipla
7. Sandoz
8. Sun Pharmaceuticals
9. Unichem Laboratories
10. Dr. Reddy's Laboratories
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Losartan Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)